Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alem...

FDA Recall #D-0248-2026 — Class III — December 16, 2025

Recall #D-0248-2026 Date: December 16, 2025 Classification: Class III Status: Ongoing

Product Description

Fesoterodine Fumarate, Extended-release Tablets, 8 mg, 30 Tablets, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-176-30

Reason for Recall

Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

Recalling Firm

Alembic Pharmaceuticals Limited — Panchmahal

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Distribution

US Nationwide and PR.

Code Information

Lot# 2405003360, Exp Date: Jan 31, 2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls